Tom Murphy
The Associated Press
Fayetteville, NC, United States
Contact Tom
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Tom:
Supply problems and insurance issues make popular weight-loss drugs hard to get
Supply problems and insurance complications have made it difficult for people to start — and stay on — Wegovy and similar medications that are transforming obesity treatment, according to doctors and patients around the country. They say getting the high-demand, injectable drugs requires persistence and a fair amount of luck. → Read More
What’s behind shortages of Adderall, Ozempic and other meds?
Shortages of drugs like Adderall are growing in the United States, and experts see no clear path to resolving them. For patients, that can mean treatment delays, medication switches and other hassles filling a prescription. → Read More
Walgreens profit slides as COVID-19 vaccinations fade in Q2
A decline in COVID-19 vaccinations and an opioid settlement cut into Walgreens second-quarter earnings, but the drugstore chain still delivered better-than-expected results. → Read More
Senators press Moderna CEO on COVID-19 vaccine price hike
Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. → Read More
Novo Nordisk plans price cuts for several insulins
Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker says that → Read More
Novo Nordisk plans price cuts for several insulins
Pressure is growing for companies to lower sky-high insulin prices. → Read More
Another drugmaker to slash prices for several insulins by up to 75%
Pressure is growing for companies to lower sky-high insulin prices. → Read More
Another drugmaker to slash prices for several insulins by up to 75%
Pressure is growing for companies to lower sky-high insulin prices. → Read More
Another drugmaker to slash prices for several insulins by up to 75%
Pressure is growing for companies to lower sky-high insulin prices. → Read More
Another drugmaker to slash prices for several insulins by up to 75%
Pressure is growing for companies to lower sky-high insulin prices. → Read More
Novo Nordisk plans price cuts for several insulins
Pressure is growing for companies to lower sky-high insulin prices. → Read More
Novo Nordisk plans price cuts for several insulins
Pressure is growing for companies to lower sky-high insulin prices. → Read More
Another drugmaker to slash prices for several insulins by up to 75%
Pressure is growing for companies to lower sky-high insulin prices. → Read More
Novo Nordisk plans price cuts for several insulins
Pressure is growing for companies to lower sky-high insulin prices. → Read More
Novo Nordisk plans price cuts for several insulins
Pressure is growing for companies to lower sky-high insulin prices. → Read More
Another drugmaker to slash prices for several insulins by up to 75%
Pressure is growing for companies to lower sky-high insulin prices. → Read More
Novo Nordisk plans price cuts for several insulins
Pressure is growing for companies to lower sky-high insulin prices. → Read More
Pfizer buys Seagen for $43B, boosts access to cancer drugs
Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue → Read More
Deadly kidnapping puts spotlight on Americans traveling to Mexico for health care
Medical tourism has been growing in popularity for years and isn't just limited to Mexico. → Read More
Deadly kidnapping puts spotlight on Americans traveling to Mexico for health care
Medical tourism has been growing in popularity for years and isn't just limited to Mexico. → Read More